Conesa D, Rello J, Vallés J, Mariscal D, Ferreres J C
Internal Medicine Department, Hospital de Sabadell, Barcelona, Spain.
Ann Pharmacother. 1995 Dec;29(12):1235-7. doi: 10.1177/106002809502901209.
To describe a patient with invasive pulmonary aspergillosis related to short-term steroid treatment.
A 78-year-old man with chronic obstructive pulmonary disease (COPD) developed an invasive pulmonary aspergillosis after short-term (less than 1 week) intravenous steroid therapy. The diagnosis was established by recovering Aspergillus fumigatus from a bronchoalveolar lavage and was confirmed by autopsy, with the additional finding of an aspergilloma.
This case is of interest for 3 reasons: (1) it illustrates that invasive aspergillosis may be followed by a rapidly progressive respiratory failure, even in the absence of a fever; (2) this patient had simultaneously an aspergilloma and an invasive aspergillosis; and (3) it confirms reports indicating that short-term steroid therapy for COPD represents a significant risk factor for opportunistic lung infections.
In patients with COPD who receive even short-term steroid therapy and who have progressive respiratory failure caused by pneumonia, invasive aspergillosis should be suspected early and acted upon accordingly.
描述一例与短期类固醇治疗相关的侵袭性肺曲霉病患者。
一名78岁慢性阻塞性肺疾病(COPD)男性患者在短期(少于1周)静脉注射类固醇治疗后发生侵袭性肺曲霉病。通过支气管肺泡灌洗培养出烟曲霉确诊,尸检进一步证实,并发现曲菌球。
该病例有三点值得关注:(1)表明侵袭性曲霉病即使无发热也可能随后迅速进展为呼吸衰竭;(2)该患者同时患有曲菌球和侵袭性肺曲霉病;(3)证实了报告指出的COPD短期类固醇治疗是机会性肺部感染的重要危险因素。
对于接受短期类固醇治疗且因肺炎导致进行性呼吸衰竭的COPD患者,应早期怀疑侵袭性肺曲霉病并采取相应措施。